Professor | Guilling Wang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Guilling Wang
Contact Information	glingwang@cmu.edu.cn
Language ability	Chinese, English
Province	Liaoning

Upload Avatar (500 x 500)

Name

Guilling Wang

Contact Information

glingwang@cmu.edu.cn

Language ability

Chinese, English

Province

Liaoning

University/Lab Affiliation and Title	China Medical University
Faculty	Life Sciences
Academic Background & Achievements	2016-2018: Research at New Jersey Cancer Institute, USA Awarded 'Outstanding Young Backbone Teacher of Higher Education in Liaoning Province' Supervised students who received 'Outstanding Master's Thesis in Liaoning Province'
Work Experience	2016-2018 - New Jersey Cancer Institute - Research on cell metabolism and lung cancer Current - China Medical University - Professor in Molecular Cell Biology
Awards	Liaoning Province Science and Technology Second Prize Liaoning Province Natural Science Academic Achievement Award Second Prize

University/Lab Affiliation and Title

China Medical University

Faculty

Life Sciences

Academic Background & Achievements

2016-2018: Research at New Jersey Cancer Institute, USA
Awarded 'Outstanding Young Backbone Teacher of Higher Education in Liaoning Province'
Supervised students who received 'Outstanding Master's Thesis in Liaoning Province'

Work Experience

2016-2018 - New Jersey Cancer Institute - Research on cell metabolism and lung cancer
Current - China Medical University - Professor in Molecular Cell Biology

Awards

Liaoning Province Science and Technology Second Prize
Liaoning Province Natural Science Academic Achievement Award Second Prize

Areas of Focus	Tumor-related gene signaling networks Cell metabolism abnormalities and tumors Integration of medicine and engineering in tumor therapy
Publications	MORC2 regulates C/EBPα-mediated cell differentiation via sumoylation., Guilling Wang, 2019 MORC protein family-related signature within human disease and cancer., Guilling Wang, 2021 Attachment of -tBu groups to aza-BODIPY core at 3,5-sites with ultra-large Stokes shift to enhance photothermal therapy through apoptosis mechanism., Guilling Wang, 2022 Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug., Guilling Wang, 2022 Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases., Guilling Wang, 2022 Synthesis of aza-BODIPYs with barrier-free rotation of the -tBu group at 3-site and enhancement of photothermal therapy by triggering cancer cell apoptosis., Guilling Wang, 2022 Engineering J-aggregates for NIR-induced meso-CF3-BODIPY nanoparticles by activated apoptosis mechanism in photothermal therapy., Guilling Wang, 2023 Construction of diene-extended meso-CF3-BODIPY for spectroscopic study and photothermal exploration., Guilling Wang, 2023 Development of functional dye with redshifted absorption based on Knoevenagel condensation at 1-site in phenyl[b]-fused BODIPY., Guilling Wang, 2023 Oncogenic MORC2 in Cancer Development and Beyond., Guilling Wang, 2023 Aza-BODIPY with two efficacious fragments for NIR light-driven photothermal therapy by triggering cancer cell apoptosis., Guilling Wang, 2023 Heavy-atom-free orthogonal configurative dye 1,7-di-anthra-aza-BODIPY for singlet oxygen generation., Guilling Wang, 2023 YTHDF1 in Tumor Cell Metabolism: An Updated Review., Guilling Wang, 2023 Unlocking the adenosine receptor mechanism of the tumour immune microenvironment., Guilling Wang, 2024 tert-Butyl substituted aza-BODIPY-based bromides for phototherapy., Guilling Wang, 2024

Areas of Focus

Tumor-related gene signaling networks
Cell metabolism abnormalities and tumors
Integration of medicine and engineering in tumor therapy

Publications

MORC2 regulates C/EBPα-mediated cell differentiation via sumoylation., Guilling Wang, 2019
MORC protein family-related signature within human disease and cancer., Guilling Wang, 2021
Attachment of -tBu groups to aza-BODIPY core at 3,5-sites with ultra-large Stokes shift to enhance photothermal therapy through apoptosis mechanism., Guilling Wang, 2022
Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug., Guilling Wang, 2022
Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases., Guilling Wang, 2022
Synthesis of aza-BODIPYs with barrier-free rotation of the -tBu group at 3-site and enhancement of photothermal therapy by triggering cancer cell apoptosis., Guilling Wang, 2022
Engineering J-aggregates for NIR-induced meso-CF3-BODIPY nanoparticles by activated apoptosis mechanism in photothermal therapy., Guilling Wang, 2023
Construction of diene-extended meso-CF3-BODIPY for spectroscopic study and photothermal exploration., Guilling Wang, 2023
Development of functional dye with redshifted absorption based on Knoevenagel condensation at 1-site in phenyl[b]-fused BODIPY., Guilling Wang, 2023
Oncogenic MORC2 in Cancer Development and Beyond., Guilling Wang, 2023
Aza-BODIPY with two efficacious fragments for NIR light-driven photothermal therapy by triggering cancer cell apoptosis., Guilling Wang, 2023
Heavy-atom-free orthogonal configurative dye 1,7-di-anthra-aza-BODIPY for singlet oxygen generation., Guilling Wang, 2023
YTHDF1 in Tumor Cell Metabolism: An Updated Review., Guilling Wang, 2023
Unlocking the adenosine receptor mechanism of the tumour immune microenvironment., Guilling Wang, 2024
tert-Butyl substituted aza-BODIPY-based bromides for phototherapy., Guilling Wang, 2024

Gene Signaling Tumor Cell Metabolism Abnormalities Therapy Medicine Engineering Integration Networks Regulation

Shuhai Lin - Xiamen University

Wei-Hong Jiang - University of Chinese Academy of Sciences

Xiaojin Song - University of Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us